Adma Biologics (ADMA) EPS (Basic) (2011 - 2026)
Adma Biologics' (ADMA) quarterly EPS (Basic) came in at -$0.56 in Q4 2025, down 361.41% YoY from $0.21 in Q4 2024, and down 466.33% on a QoQ basis from $0.15 in Q3 2025.
Adma Biologics (ADMA) EPS (Basic) (2011 - 2026) Analysis & Trends
Adma Biologics (ADMA) has 13 years of EPS (Basic) data on file, last reported at -$0.56 in Q4 2025.
- Quarterly EPS (Basic) fell 361.41% year-over-year to -$0.56 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.15 (down 125.76% YoY) and the FY2025 annual result came in at -$0.15, down 125.76% from the prior year.
- EPS (Basic) slipped to -$0.56 in Q4 2025, from $0.15 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.21 in Q4 2024 to a low of -$0.56 in Q4 2025.
- A 5-year average of -$0.02 and a median of -$0.03 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2024 — EPS (Basic) surged 1244.49% — and 2025, when it plunged 361.41%.
- Tracing ADMA's EPS (Basic) over 5 years: stood at -$0.1 in 2021, then soared by 38.33% to -$0.06 in 2022, then jumped by 179.37% to $0.05 in 2023, then surged by 352.33% to $0.21 in 2024, then sank by 361.41% to -$0.56 in 2025.
- The last three EPS (Basic) figures came in at -$0.56 (Q4 2025), $0.15 (Q3 2025), and $0.14 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Adma Biologics | 2.13 Bn | 2.00 Bn | 86.28 Mn | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.17 |
| Dec 31, 2025 | -0.56 |
| Sep 30, 2025 | 0.15 |
| Jun 30, 2025 | 0.14 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.15 |
| Jun 30, 2024 | 0.14 |
| Mar 31, 2024 | 0.08 |
| Dec 31, 2023 | 0.05 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | -0.03 |
| Mar 31, 2023 | -0.03 |
| Dec 31, 2022 | -0.06 |
| Sep 30, 2022 | -0.08 |
| Jun 30, 2022 | -0.07 |
| Mar 31, 2022 | -0.09 |
| Dec 31, 2021 | -0.10 |
| Sep 30, 2021 | -0.13 |
| Jun 30, 2021 | -0.15 |